Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
331-345 of 2993 results
Aethlon Medical announces Zika Virus data
Aethlon Medical, a developer of immunotherapeutic technologies to combat infectious disease and cancer, announced that its researchers have completed in vitro studies that demonstrate the rapid capture of Zika virus by the Aethlon Hemopurifier.
Diagnostics > In Vitro Diagnostics > News
Community Health Ventures and Medline launch new group purchasing partnership
Community health centers play a key clinical role in helping patients in underserved areas. In fact, nearly 1 in 14 people receive care at these facilities.
Diagnostics > In Vitro Diagnostics > News
OncoCyte begins analytical verification study for lung cancer diagnostic test
By MDBR Staff Writer
Blood-based tests developer OncoCyte has commenced the analytical verification study for its lung cancer diagnostic test.
Diagnostics > In Vitro Diagnostics > News
Alere receives IVD CE Mark for new lateral flow assay analyzer
By MDBR Staff Writer
Alere has secured in-vitro diagnostic (IVD) CE marking in Europe for its new diagnostic analyzer, which can be utilized in both point-of-care and laboratory settings.
Diagnostics > In Vitro Diagnostics > News
Magellan Diagnostics gets Chinese approval for LeadCare II blood lead testing system
By MDBR Staff Writer
The China Food and Drug Administration (CFDA) has approved Magellan Diagnostics' LeadCare II blood lead testing system.
Diagnostics > In Vitro Diagnostics > News
Avacta, Leeds University receive £3.8m grant to develop new diagnostic tests
By MDBR Staff Writer
Avacta Group and Leeds University have received a £3.8m grant from the UK’s Medical Research Council to develop new diagnostic tests.
Diagnostics > In Vitro Diagnostics > News
Personal Genome Diagnostics, Illumina partner to develop two in-vitro diagnostic test kits
By MDBR Staff Writer
Personal Genome Diagnostics (PGDx) has signed an agreement with Illumina to develop cancer in-vitro diagnostic (IVD) test kits.
Diagnostics > In Vitro Diagnostics > News
FDA grants emergency use authorization for Luminex's Zika Virus molecular detection assay
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Luminex's xMAP MultiFLEX Zika RNA assay.
Diagnostics > In Vitro Diagnostics > News
Pacific Biosciences releases new software and chemistry for Sequel system
Pacific Biosciences of California announced it has released a set of key updates for the Sequel system, the company’s latest product based on its single molecule, real-time (SMRT) sequencing technology.
Diagnostics > In Vitro Diagnostics > News
Myriad Genetics to acquire Assurex Health for $225m
Molecular diagnostics solutions provider Myriad Genetics has signed an agreement to acquire Assurex Health for around $225m.
Diagnostics > In Vitro Diagnostics > News
Interpace Diagnostics receives New York State approval for thyroid test
Interpace Diagnostics announced that the New York State Department of Health has reviewed and approved ThyraMir, the Company's micro RNA gene-expression based test, for marketing in New York State.
Diagnostics > In Vitro Diagnostics > News
The Technology Partnership launches new point-of-care diagnostic instrument development service
The Technology Partnership (TTP), a world-leading technology and development organisation, announced the launch of Desktop Biology.
Diagnostics > In Vitro Diagnostics > News
Rosetta Genomics introduces New NGS-based assay to detect somatic mutations
Rosetta Genomics has expanded its molecular diagnostics test portfolio with the introduction of OncoGxSelect next generation sequencing (NGS)-based test.
Diagnostics > In Vitro Diagnostics > News
MD Anderson Cancer Center research demonstrates clinical applicability of Angle’s blood biopsy technology
Angle plc, the UK-based medical diagnostics company, announces a poster presentation by researchers from the University of Texas MD Anderson Cancer Center describing clinically-relevant results from a study using its lead product, the Parsortix cell separation system, to harvest breast cancer cells in blood for subsequent molecular characterization.
Diagnostics > In Vitro Diagnostics > News
Seegene launches new in-silico-based multiplex real-time PCR assays
By MDBR Staff Writer
Seegene has expanded its product portfolio with the introduction of new in-silico-based multiplex real-time PCR assays.
Diagnostics > In Vitro Diagnostics > News
331-345 of 2993 results